Roche, GSK and Pfizer Remain the Most Prolific Big Pharma Dealmakers
By Heather Cartwright; Taskin Ahmed
PharmaDeals Corp-METRx: Vol 2012 Issue 4 (Table of Contents)
Published: 27 Nov-2012
DOI: 10.3833/pdcmx.v2012.i4.1853 ISSN: 2047-7007
Section: Quarterly Review
Fulltext:
Abstract
Quarterly Review 2012
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018